Amy Johnson MD

Cutaneous Lymphoma, Melanoma

Physician

Summary

Amy Johnson, MD, is an oncologist practicing in Cleveland, OH, with a sub-specialty in cutaneous lymphoma. She received her B.S., with a major in Biology and minor in Chemistry, from the University of Missouri-Kansas City, graduating summa cum laude. She then attended medical school at the University of Missouri-Columbia, and later completed a residency in Internal Medicine at Indiana University School of Medicine/Ball Memorial. She also completed a Dermatology residency and fellowship at Case Western Reserve University/University Hospitals Cleveland Medical Center. In addition, she completed a fellowship in Cutaneous Lymphomas at Ohio State University. She has several publications on dermatological health, particularly cutaneous lymphomas. Dr. Johnson has received numerous honors and awards throughout her educational journey, including the Certification in Basic Quality and Safety, the Joseph Hurley, MD scholarship, the Paul C. Vescovo, Jr. Medical Staff Scholarship, the Vice Chancellor Honor Award, and a fellowship from Phi Kappa Phi.

Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Dermatology, 2024 - 2027
University HospitalsFellowship, 2020 - 2023
Ohio State UniversityFellowship, Cutaneous Lymphomas, 2019 - 2020
Indiana University School of Medicine/Ball MemorialResidency, Internal Medicine, 2018 - 2019
University of Missouri-Columbia School of MedicineClass of 2018
University of Missouri-Kansas CityB.S., Major: Biology; Minor: Chemistry, Summa Cum Laude, 2014

Certification in Basic Quality and Safety 2018
Joseph Hurley, MD scholarship 2016
Fellow Phi Kappa Phi, 2014
Paul C. Vescovo, Jr. Medical Staff Scholarship 2014
Recipient, Vice Chancellor Honor Award 2014
Mel Carnahan Memorial Scholarship University of Missouri System Board of Curators, 2013
Elizabeth Spelman Health Careers Scholarship 2010
Trustee Scholar University of Missouri-Kansas City, 2010
Biology Honors and Honors Program Scholar Designation University of Missouri-Kansas City
Golden Key
Mortar Board
Omicron Delta Kappa
Phi Kappa Phi
Join now to see all

PubMed

Journal Articles

Topical imiquimod monotherapy for indolent primary cutaneous B‐cell lymphomas: a single‐institution experience
Hwang S, Johnson A, Fabbro S, Hastings J, et. al, British Journal of Dermatology, 8/1/2020
Psychology Dramatized: Shutter Island Film Analysis
Amy G. Johnson and Dr. Melisa Rempfer, Journal of Psychological Inquiry, 1/1/2013

Abstracts/Posters

Brentuximab Vedotin (BV) and Lenalidomide (Len) in Relapsed and Refractory (r/r) Cutaneous (CTCL) and Peripheral (PTCL) T-Cell Lymphomas; A Planned Interim Analysis of...
Amy Johnson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Oncology fellowsâ€™ knowledge and current practice regarding outpatient oncology and palliative care.
2019 ASCO Annual Meeting - 6/1/2019
Resolving ethical conflicts in health care: Consult case regarding medical futility, surrogate decision making.
1/1/2018
Polypodium Leucotomos- Why Not?
University of Missouri - 1/1/2017
Endothelial ENaC Inhibition Attenuates Western Diet-Induced Endothelial Dysfunction in Female Mice.
University of Missouri - 1/1/2015
Investigating the Role of Sponge and Myoblast city Proteins in the Development of the Dorsal Vessel in Drosophila Melanogaster.
University of Missouri- Kansas City - 1/1/2013
Join now to see all

Other

Honors Scholar Thesis: Implications of beta-hydroxy- beta-methylbutyrate Supplementation on Expression of Key Regulatory Genes during C2C12 Myoblast Differentiation.
Amy G. Johnson and Dr. Marco Brotto, PhD, BSN
University of Missouri- Kansas City - 1/1/2014

Development of predictive psoriasis response endotypes using single cell transcriptomics in ustekinumab responders versus non-respondersLEO Foundation ($558,000)2022–2024
Correlation between clinical markers and transcriptome analyses in psoriasis patients.National Psoriasis Foundation ($50,000)2021–2022